Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor

Toxicological Sciences

Volumn 124, Issue 1, 2011, Pages 1-22

  Denison, Michael S ^a   Soshilov, Anatoly A ^a   He, Guochun ^a   Degroot, Danica E ^a   Zhao, Bin ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

Author keywords

Ah receptor; AhR; Dioxin; HAHs; Mechanism; PAHs; Promiscuity

Indexed keywords

AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CELL NUCLEUS RECEPTOR; DIOXIN; LIGAND;

ARTICLE; COMPLEX FORMATION; DIMERIZATION; HUMAN; LIGAND BINDING; MOLECULAR GENETICS; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SPECIES DIFFERENCE; TISSUE SPECIFICITY; TOXICOLOGICAL PARAMETERS;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TETRACHLORODIBENZODIOXIN;

EID: 84155196846     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr218     Document Type: Article

References (168)

1. Aarts, J. M. M. J.G., Denison, M. S., Cox, M. A., Schalk, M. A., Garrison, P. M., Tullis, K., de Haan, L. H., and Brouwer, A. (1996). Species-specific antagonism of Ah receptor action by 2,2',5,5'-tetrachloroand 2,2',3,3',4,4'-hexachlorobiphenyl. Eur. J. Pharmacol. 293, 463-474.
2. Abdelrahim, M., Ariazi, E., Kim, K., Khan, S., Barhoumi, R., Burghardt, R., Liu, S., Hill, D., Finnell, R., Wlodarczyk, B., et al. (2006). 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Res. 66, 2459-2467.
3. Abdelrahim, M., Smith, R., III., and Safe, S. (2003). Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ahresponsiveness in MCF-7 and HepG2 cancer cells. Mol. Pharmacol. 63, 1373-1381.
4. Abel, J., and Haarmann-Stemmann, T. (2010). An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 391, 1235-1248.
5. Abnet, C. C., Tanguay, R. L., Heideman, W., and Peterson, R. E. (1999). Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. Toxicol. Appl. Pharmacol. 159, 41-51.
6. Ahmed, S., Valen, E., Sandelin, A., and Matthews, J. (2009). Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters. Toxicol. Sci. 111, 254-266.
7. Antelmann, H., and Helmann, J. D. (2011). Thiol-based redox switches and gene regulation. Antioxid. Redox Signal. 14, 1049-1063.
8. Anttila, S., Lei, X. D., Elovaara, E., Karjalainen, A., Sun, W., Vainio, H., and Hankinson, O. (2000). An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics 10, 741-751.
9. Anttila, S., Tuominen, P., Hirvonen, A., Nurminen, M., Karjalainen, A., Hankinson, O., and Elovaara, E. (2001). CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11, 501-509.
10. Baba, T., Mimura, J., Gradin, K., Kuroiqa, A., Watanabe, T., Matsuda, Y., Inazawa, J., Sogawa, K., and Fujii-Kuriyama, Y. (2001). Structure and expression of the Ah receptor repressor gene. J. Biol. Chem. 276, 33101-33110.
11. Backlund, M., and Ingelman-Sundberg, M. (2004). Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. Mol. Pharmacol. 65, 416-425.
12. Bank, P. A., Yao, E. F., Phelps, C. L., Harper, P. A., and Denison, M. S. (1992). Species-specific binding of transformed Ah receptor to a dioxin responsive transcriptional enhancer. Eur. J. Pharmacol. 228, 85-94.
13. Barnes-Ellerbe, S., Knudson, K. E., and Puga, A. (2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Mol. Pharmacol. 66, 502-511.
14. Beischlag, T. V., Morales, J. L., Hollingshead, B. D., and Perdew, G. H. (2008). The aryl hydrocarbon receptor complex in the control of gene expression. Crit. Rev. Eukaryot. Gene Exp. 18, 207-250.
15. Bisson, W. H., Koch, D. C., O'Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S. K. (2009). Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands. J. Med. Chem. 52, 5635-5641.
16. Biswas, G., Srinivasan, S., Anandatheerthavarada, H. K., and Avadhani, N. G. (2008). Dioxin-mediated tumor progression through activation of mitochondria-to-nucleus stress signaling. Proc. Natl. Acad. Sci. U.S.A. 105, 186-191.
17. Bohonowych, J. E., and Denison, M. S. (2007). Persistent binding of ligands to the aryl hydrocarbon receptor. Toxicol. Sci. 98, 99-110.
18. Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., Walker, J. R., Flaveny, C. A., Perdew, G. H., Denison, M. S., et al. (2010). Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329, 1345-1348.
19. Boutros, P. C., Bielefeld, K. A., Pohjanvirta, R., and Harper, P. A. (2009). Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR null mice. Toxicol. Sci. 112, 245-256.
20. Bradfield, C. A., Kende, A. S., and Poland, A. (1988). Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin. Mol. Pharmacol. 34, 229-237.
21. Brunnberg, S., Pettersson, K., Rydin, E., Matthews, J., Hanberg, A., and Pongratz, I. (2003). The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc. Natl. Acad. Sci. U.S.A. 100, 6517-6522.
22. Bui, L. C., Tomkiewicz, C., Chevallier, A., Pierre, S., Bats, A. S., Mota, S., Raingeaud, J., Pierre, J., Diry, M., Transy, C., et al. (2009). Nedd9/Hef1/ Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene 28, 3642-3651.
23. Bunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., and Bradfield, C. A. (2008). Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicol. Sci. 106, 83-92.
24. Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., and Bradfield, C. A. (2003). Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J. Biol. Chem. 278, 17767-17774.
25. Card, P. B., Erbel, P. J., and Gardner, K. H. (2005). Structural basis of Arnt PAS-B dimerization: use of a common beta-sheet interface for hetero- and homodimerization. J. Mol. Biol. 353, 664-678.
26. Chang, C. Y., and Puga, A. (1998). Constitutive activation of the aromatic hydrocarbon receptor. Mol. Cell. Biol. 18, 525-535.
27. Chang, X., Fan, Y., Karyala, S., Schwemberger, S., Tomlinson, C. R., Sartor, M. A., and Puga, A. (2007). Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol. Cell. Biol. 27, 6127-6139.
28. Chen, I., McDougal, A., Wang, F., and Safe, S. (1998). Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19, 1631-1639.
29. Chen, Y. H., and Tukey, R. H. (1996). Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271, 26261-26266.
30. Chiaro, C. R., Patel, R. D., Marcus, C. B., and Perdew, G. H. (2007). Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway. Mol. Pharmacol. 72, 1369-1379.
31. Chopra, M., and Schrenk, D. (2011). Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death. Crit. Rev. Toxicol. 41, 292-320.
32. Conney, A. H. (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875-4917.
33. Connor, K. T., and Aylward, L. L. (2006). Human response to dioxin: aryl hydrocarbon recepytor (AhR) molecular structure, function, and doseresponse data for enzyme induction indicate an impaired human AhR. J. Toxicol. Environ. Health B Crit. Rev. 9, 147-171.
34. De Abrew, K. N., Kaminski, N. E., and Thomas, R. S. (2010). An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation. Toxicol. Sci. 118, 454-469.
35. De Bosscher, K. (2010). Selective glucocorticoid receptor modulators. J. Steroid Biochem. Mol. Biol. 120, 96-104.
36. de Oliveira, S. K., and Smolenski, A. (2009). Phosphodiesterases link the aryl hydrocarbon receptor complex to cyclic nucleotide signaling. Biochem. Pharmacol. 77, 723-733.
37. Denison, M. S., and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
38. Denison, M. S., Phelen, D., and Elferink, C. J. (1998b). The Ah receptor signal transduction pathway. In Xenobiotics, Receptors and Gene Expression (M. S. Denison and W. G. Helferich, Eds.), pp. 3-33. Taylor and Francis, Philadelphia, PA.
39. Denison, M. S., Seidel, S. D., Rogers, W. J., Ziccardi, M., Winter, G. M., and Heath-Pagliuso, S. (1998a). Natural and synthetic ligands for the Ah receptor. In Molecular Biology Approaches to Toxicology (A. Puga and K. B. Wallace, Eds.), pp. 393-410. Taylor & Francis, Philadelphia, PA.
40. Denison, M. S., Vella, L. M., and Okey, A. B. (1986). Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin: species differences in molecular properties of the receptor from mouse and rat hepatic cytosol. J. Biol. Chem. 261, 3987-3995.
41. Denison, M. S., and Wilkinson, C. F. (1985). Identification of the Ah receptor in selected mammalian species and its role in the induction of aryl hydrocarbon hydroxylase. Eur. J. Biochem. 147, 429-435.
42. Dere, E., Forgacs, A. L., Zacharewski, T., and Burgoon, L. (2011a). Genomewide computational analysis of dioxin response element location and distribution in the human, mouse and rat genomes. Chem. Res. Toxicol. 24, 494-504.
43. Dere, E., Lee, A. W., Burgoon, L. D., and Zacharewski, T. R. (2011b). Differences in TCDD-elicited gene expression profiles in human HepG2, mouse Hepa1c1c7 and rat H4IIe hepatoma cells. BMC Genomics 12, 193.
44. DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., and Perdew, G. H. (2010). Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol. Sci. 115, 89-97.
45. Diani-Moore, S., Ram, P., Li, X., Mondal, P., Youn, D. Y., Sauve, A. A., and Rifkind, A. B. (2010). Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect. J. Biol. Chem. 285, 38801-38810.
46. Diry, M., Tomkiewicz, C., Koehle, C., Coumoul, X., Bock, K. W., Barouki, R., and Transy, C. (2006). Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 25, 5570-5574.
47. Erbel, P. J., Card, P. B., Karakuzu, O., Bruick, R. K., and Gardner, K. H. (2003). Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible factor. Proc. Natl. Acad. Sci. U.S.A. 100, 15504-15509.
48. Everett, C. J., Mainous, A. G., III., Frithsen, I. L., Player, M. S., and Matheson, E. M. (2008). Commentary on the association of polychlorinated biphenyls with hypertension. Environ. Res. 108, 428-429.
49. Flaveny, C., Reen, R. K., Kusnadi, A., and Perdew, G. H. (2008). The mouse and human Ah receptor different in recognition of LXXLL motifs. Arch. Biochem. Biophys. 471, 215-223.
50. Flaveny, C. A., Murray, I. A., and Perdew, G. H. (2010). Differential gene regulation by the human and mouse aryl hydrocarbon receptor. Toxicol. Sci. 114, 217-225.
51. Flaveny, C. A., and Perdew, G. H. (2009). Transgenic humanized AHR mouse reveals differences between human and mouse AHR ligand selectivity. Mol. Cell. Pharmacol. 1, 119-123.
52. Furness, S. G., and Whelan, F. (2009). The pleiotropy of dioxin toxicity- xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles. Pharmacol. Ther. 124, 336-353.
53. Gonzalez, F. J., and Fernandez-Salguero, P. (1998). The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab. Dispos. 26, 1194-1198.
54. Goryo, K., Suzuki, A., Del Carpio, C. A., Siizaki, K., Kuriyama, E., Mikami, Y., Kinoshita, K., Yasumoto, K., Rannug, A., et al. (2007). Identification of amino acid residues in the Ah receptor involved in ligand binding. Biochem. Biophys. Res. Commun. 354, 396-402.
55. Gouédard, C., Barouki, R., and Morel, Y. (2004). Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 24, 5209-5222.
56. Haarmann-Stemmann, T., Bothe, H., and Abel, J. (2009). Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem. Pharmacol. 77, 508-520.
57. Hahn, M. E., Allan, L. L., and Sherr, D. H. (2009). Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochem. Pharmacol. 77, 485-497.
58. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
59. Hankinson, O. (2005). Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch. Biochem. Biophys. 433, 379-386.
60. Harper, P. A., Wong, J. Y., Lam, M. S., and Okey, A. B. (2002). Polymorphisms in the human AH receptor. Chem. Biol. Interact. 141, 161-187.
61. Hayden, M. S., and Ghosh, S. (2008). Shared principles in NF-kappaB signaling. Cell 231, 344-362.
62. Hayes, K. R., Zastrow, G. M., Nukaya, M., Pande, K., Glover, E., Maufort, J. P., Liss, A. L., Liu, Y., Moran, S. M., Vollrath, A. L., et al. (2007). Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem. Res. Toxicol. 20, 1573-1581.
63. Head, J. A., Hahn, M. E., and Kennedy, S. W. (2008). Key amino acids in the aryl hydrocarbon receptor predict dioxin sensitivity in avian species. Environ. Sci. Technol. 42, 7535-7541.
64. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., et al. (2007). Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87, 905-931.
65. Henklovà, P., Vrzal, R., Ulrichovà, J., and Dvoràk, Z. (2008). Role of mitogenactivated protein kinases in aryl hydrocarbon receptor signaling. Chem. Biol. Interact. 172, 93-104.
66. Henry, E. C., and Gasiewicz, T. A. (1993). Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. J. 294, 95-101.
67. Henry, E. C., and Gasiewicz, T. A. (2003). Agonist but not antagonist ligands induce conformational change in the mouse aryl hydrocarbon receptor as detected by partial proteolysis. Mol. Pharmacol. 63, 392-400.
68. Henry, E. C., and Gasiewicz, T. A. (2008). Molecular determinants of speciesspecific agonist and antagonist activity of a substituted flavone towards the aryl hydrocarbon receptor. Arch. Biochem. Biophys. 472, 77-88.
69. Hestermann, E. V., and Brown, M. (2003). Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor. Mol. Cell. Biol. 23, 7920-7925.
70. Hsia, M. T., and Kreamer, B. L. (1985). Delayed wasting syndrome and alterations of liver gluconeogenic enzymes in rats exposed to the TCDD congener 3,3',4,4'-tetrachloroazoxybenzene. Toxicol. Lett. 25, 247-258.
71. Huang, G., and Elferink, C. J. (2005). Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol. Pharmacol. 67, 88-96.
72. Humblet, O., Birnbaum, L., Rimm, E., Mittleman, M. A., and Hauser, R. (2008). Dioxins and cardiovascular disease mortality. Environ. Health Perspect. 116, 1443-1448.
73. Johnson, D. G., and Walker, C. L. (1999). Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312.
74. Karchner, S. I., Franks, D. G., Kennedy, S. W., and Hahn, M. E. (2006). The molecular basis for differential dioxin sensitivity in birds: role of the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U.S.A. 103, 6252-6257.
75. Karras, J. G., Morris, D. L., Matulka, R. A., Kramer, C. M., and Holsapple, M. P. (1996). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion. Toxicol. Appl. Pharmacol. 137, 275-284.
76. Kazmin, D., Prytkova, T., Cook, C. E., Wolfinger, R., Chu, T. M., Beratan, D., Norris, J. D., Chang, C. Y., and McDonnell, D. P. (2006). Linking ligandinduced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators. Mol. Endocrinol. 20, 1201-1217.
77. Kerkvliet, N. I. (2009). AHR-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharmacol. 77, 746-760.
78. Kewley, R. J., Whitelaw, M. L., and Chapman-Smith, A. (2004). The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell. Biol. 36, 189-204.
79. Kikuchi, H., Kato, H., Mizuno, M., Hossain, A., Ikawa, S., Miyazaki, J., and Watanabe, M. (1996). Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction. Arch. Biochem. Biophys. 334, 235-240.
80. Kim, Y. H., Shim, Y. J., Shin, Y. J., Sul, D., Lee, E., and Min, B. H. (2009). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces calcium influx through T-type calcium channel and enhances lysosomal exocytosis and insulin secretion in INS-1 cells. Int. J. Toxicol. 28, 151-161.
81. Kinehara, M., Fukuda, I., Yoshida, K., and Ashida, H. (2008). High-throughput evaluation of aryl hydrocarbon receptor-binding sites selected via chromatin immunoprecipitation-based screening in Hepa-1c1c7 cells stimulated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Genes Genet. Syst. 83, 455-468.
82. Kinehara, M., Fukuda, I., Yoshida, K., and Ashida, H. (2009). Aryl hydrocarbon receptor-mediated induction of the cytosolic phospholipase A(2) alpha gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse hepatoma Hepa1c1c7 cells. J. Biosci. Bioeng. 108, 277-281.
83. Kolluri, S. K., Weiss, C., Koff, A., and Gottlicher, M. (1999). p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13, 1742-1753.
84. Kopec, A. K., Burgoon, L. D., Ibrahim-Aibo, D., Burg, A. R., Lee, A. W., Tashiro, C., Potter, D., Sharratt, B., Harkema, J. R., Rowlands, J. C., et al. (2010). Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice. Toxicol. Sci. 118, 286-297.
85. Kopf, P. G., Scott, J. A., Agbor, L. N., Boberg, J. R., Elased, K. M., Huwe, J. K., and Walker, M. K. (2010). Cytochrome P4501A1 is required for vascular dysfunction and hypertension induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 117, 537-546.
86. Kraemer, S. A., Arthur, K. A., Denison, M. S., Smith, W. L., and DeWitt, D. L. (1996). Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8,-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys. 330, 319-328.
87. Lee, D. H., Lee, I. K., Porta, M., Steffes, M., and Jacobs, D. R., Jr. (2007). Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the national health and nutrition examination survey 1999-2002. Diabetologia 50, 1841-1851.
88. Lees, M. J., and Whitelaw, M. L. (1999). Multiple roles of ligand in transforming the dioxin receptor to an active basic helix-loop-helix/PAS transcription factor complex with the nuclear protein Arnt. Mol. Cell. Biol. 19, 5811-5822.
89. Li, W., and Matsumura, F. (2008). Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes. Biochemistry 47, 13997-14008.
90. Li, W., Vogel, C. F., Wu, D., and Matsumura, F. (2010a). Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice. Biol. Chem. 391, 1205-1219.
91. Li, Y., Li, Y., Zhang, T., and Chan, W. K. (2010b). The aryl hydrocarbon receptor nuclear translocator-interacting protein 2 suppresses the estrogen receptor signaling via an Arnt-dependent mechanism. Arch. Biochem. Biophys. 502, 121-129.
92. Linden, J., Lensu, S., Tuomisto, J., and Pohjanvirta, R. (2010). Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance. Front. Neuroendocrinol. 31, 452-478.
93. Liu, S., Abdelrahim, M., Khan, S., Ariazi, E., Jordan, V. C., and Safe, S. (2006). Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol. Chem. 387, 1209-1213.
94. Long, W. P., Pray-Grant, M., Tsai, J. C., and Perdew, G. H. (1998). Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol. Pharmacol. 53, 691-700.
95. Luecke, S., Wincent, E., Backlund, M., Rannug, U., and Rannug, A. (2010). Cytochrome P4501A1 gene regulation by UVB involves crosstalk between the aryl hydrocarbon receptor and nuclear factor kappaB. Chem. Biol. Interact. 184, 466-473.
96. Lusska, A., Shen, E., and Whitlock, J. P., Jr. (1993). Protein-DNA interactions at a dioxin-responsive enhancer. Analysis of six bona fide DNA-binding sites for the liganded Ah receptor. J. Biol. Chem. 268, 6575-6580.
97. Marinković, N., Pašalić, D., Ferenčak, G., Gršković, B., and Stavljenić Rukavina, A. (2010). Dioxins and human toxicity. Arh. Hig. Rada. Toksikol. 61, 445-453.
98. Marlowe, J. L., Knudsen, E. S., Schwemberger, S., and Puga, A. (2004). The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J. Biol. Chem. 279, 29013-29022.
99. Marlowe, J. L., and Puga, A. (2010). Novel AHR interactions. In Comprehensive Toxicology, Vol. 2, Cellular and Molecular Toxicology, 2nd ed. (K. Ramos, Ed.), pp. 93-116. Academic Press, New York, NY.
100. Matikainen, T., Perez, G. I., Jurisicova, A., Pru, J. K., Schlezinger, J. J., Ryu, H. Y., Laine, J., Sakai, T., Korsmeyer, S. J., Casper, R. F., et al. (2001). Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat. Genet. 28, 355-360.
101. Matsumura, F. (2009). The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochem. Pharmacol. 77, 608-626.
102. Matthews, J., Wihlen, B., Thomsen, J., and Gustafsson, J. A. (2005). Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell. Biol. 25, 5317-5328.
103. McDougal, A., Wilson, C., and Safe, S. (1997). Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists. Cancer Lett. 120, 53-63.
104. McMillan, B. J., and Bradfield, C. A. (2007a). The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol. Pharmacol. 72, 487-498.
105. McMillan, B. J., and Bradfield, C. A. (2007b). The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 104, 1412-1417.
106. Mocarelli, P., Needham, L. L., Marocchi, A., Patterson, D. G., Jr, Brambilla, P., Gerthoux, P. M., Meazza, L., and Carreri, V. (1991). Serum concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin and test results from selected residents of Seveso, Italy. J. Toxicol. Environ. Health 32, 357-366.
107. Monostory, K., Pascussi, J. M., Kobori, L., and Dvorak, Z. (2009). Hormonal regulation of CYP1A expression. Drug Metab. Rev. 41, 547-572.
108. Moriguchi, T., Motohashi, H., Hosoya, T., Nakajima, O., Takahashi, S., Ohsako, S., Aoki, Y., Nishimura, N., Tohyama, C., Fujii-Kuriyama, Y., et al. (2003). Distinct response to dioxin in an aryl hydrocarbon receptor (AHR)-humanized mouse. Proc. Natl. Acad. Sci. U.S.A. 100, 5652-5657.
109. Murray, I. A., Flaveny, C. A., Chiaro, C. R., Sharma, A. K., Tanos, R. S., Schroeder, J. C., Amin, S. G., Bisson, W. H., Kolluri, S. K., and Perdew, G. H. (2011). Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-a-naphthoflavone. Mol. Pharmacol. 79, 508-519.
110. Murray, I. A., Krishnegowda, G., DiNatale, B. C., Flaveny, C., Chiaro, C., Lin, J. M., Sharma, A. K., Amin, S., and Perdew, G. H. (2010a). Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties. Chem. Res. Toxicol. 23, 955-966.
111. Murray, I. A., Morales, J. L., Flaveny, C. A., Dinatale, B. C., Chiaro, C., Gowdahalli, K., Amin, S., and Perdew, G. H. (2010b). Evidence for ligandmediated selective modulation of aryl hydrocarbon receptor activity. Mol. Pharmacol. 77, 247-254.
112. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279, 23847-23850.
113. Nebert, D. W., and Jensen, N. M. (1979). The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. CRC Crit. Rev. Biochem. 6, 401-437.
114. Nguyen, L. P., and Bradfield, C. A. (2008). The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21, 102-106.
115. Norris, J. D., Joseph, J. D., Sherk, A. B., Juzumiene, D., Turnbull, P. S., Rafferty, S. W., Cui, H., Anderson, E., Fan, D., Dye, D. A., et al. (2009). Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chem. Biol. 16, 452-460.
116. Noy, N. (2007). Ligand specificity of nuclear hormone receptors: sifting through promiscuity. Biochemistry 46, 13461-13467.
117. Nukaya, M., Walisser, J. A., Moran, S. M., Kennedy, G. D., and Bradfield, C. A. (2010). Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydrocarbon receptor-mediated adaptive and toxic responses in liver. Toxicol. Sci. 118, 554-563.
118. Oesch-Bartlomowicz, B., Huelster, A., Wiss, O., Antoniou-Lipfert, P., Dietrich, C., Arand, M., Weiss, C., Bockamp, E., and Oesch, F. (2005). Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 102, 9218-9223.
119. Okey, A. B. (2007). An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. Toxicol. Sci. 98, 5-38.
120. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., Yanagisawa, J., et al. (2003). Modulation of oestrogen receptor signaling by association with the activated dioxin receptor. Nature 423, 545-550.
121. Ozers, M. S., Ervin, K. M., Steffen, C. L., Fronczak, J. A., Lebakken, C. S., Carnahan, K. A., Lowery, R. G., and Burke, T. J. (2005). Analysis of liganddependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization. Mol. Endocrinol. 19, 25-34.
122. Pandini, A., Denison, M. S., Song, Y., Soshilov, A., and Bonati, L. (2007). Structural and functional characterization of the AhR ligand binding domain by homology modeling and mutational analysis. Biochemistry 23, 696-708.
123. Pandini, A., Soshilov, A. A., Song, Y., Zhao, J., Bonati, L., and Denison, M. S. (2009). Detection of the TCDD binding fingerprint within the Ah receptor ligand binding domain by structurally driven mutagenesis and functional analysis. Biochemistry 48, 5972-5983.
124. Pang, P. H., Lee, Y. H., Lee, Y. H., Hou, H. H., Hsu, S. P., and Juan, S. H. (2008). Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells. J. Cell. Physiol. 215, 161-171.
125. Pansoy, A., Ahmed, S., Valen, E., Sandelin, A., and Matthews, J. (2010). 3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters. Toxicol. Sci. 117, 90-100.
126. Park, J. Y., Shigenaga, M. K., and Ames, B. N. (1996). Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 93, 2322-2327.
127. Park, S., Dong, B., and Matsumura, F. (2007). Rapid activation of c-Src kinase by dioxin is mediated by the Cdc37-HSP90 complex as part of Ah receptor signaling in MCF10A cells. Biochemistry 46, 899-908.
128. Patel, R. D., Murray, I. A., Flaveny, C. A., Kusnadi, A., and Perdew, G. H. (2009). Ah receptor represses acute-phase response gene expression without binding to its cognate response element. Lab. Invest. 89, 1-13.
129. Petkov, P. I., Rowlands, J. C., Budinsky, R., Zhao, B., Denison, M. S., and Mekenyan, O. (2010). Mechanism based common reactivity pattern (COREPA) modeling of AhR binding affinity. SAR QSAR Environ. Res. 21, 187-214.
130. Pierre, S., Bats, A. S., Chevallier, A., Bui, L. C., Ambolet-Camoit, A., Garlatti, M., Aggerbeck, M., Barouki, R., and Coumoul, X. (2011). Induction of the Ras activator Son of Sevenless 1 by environmental pollutants mediates their effects on cellular proliferation. Biochem. Pharmacol. 81, 304-313.
131. Poland, A., Glover, E., and Kende, A. S. (1976). Sterospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 351, 4936-4946.
132. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-542.
133. Poland, A., Palen, D., and Glover, E. (1994). Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 146, 915-921.
134. Pollenz, R. S. (2002). The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem. Biol. Interact. 141, 41-61.
135. Puga, A., Hoffer, A., Zhou, S., Bohm, J. M., Leikauf, G. D., and Shertzer, H. G. (1997). Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem. Pharmacol. 54, 1287-1296.
136. Puga, A., Ma, C., and Marlowe, J. L. (2009). The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 77, 713-722.
137. Rogers, J. M., and Denison, M. S. (2000). Analysis of the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human ovarian carcinoma (BG-1) cells. Mol. Pharmacol. 61, 1393-1403.
138. Ruegg, J., Swedenborg, E., Wahlstrom, D., Escande, A., Balaguer, P., Pettersson, K., and Pongratz, I. (2008). The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor b-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin. Mol. Endocrinol. 22, 304-316.
139. Sadar, M. D., Ash, R., Sundqvist, J., Olsson, P. E., and Andersson, T. B. (1996a). Phenobarbital induction of CYP1A1 gene expression in a primary culture of rainbow trout hepatocytes. J. Biol. Chem. 271, 17635-17643.
140. Sadar, M. D., Westlind, A., Blomstrand, F., and Andersson, T. B. (1996b). Induction of CYP1A1 by GABA receptor ligands. Biochem. Biophys. Res. Commun. 229, 231-237.
141. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 21, 51-88.
142. Safe, S., Wang, F., Porter, W., Duan, R., and McDougal, A. (1998). Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol. Lett. 102-103, 343-347.
143. Schroeder, J. C., Dinatale, B. C., Murray, I. A., Flaveny, C. A., Liu, Q., Laurenzana, E. M., Lin, J. M., Strom, S. C., Omiecinski, C. J., Amin, S., et al. (2010). The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry 49, 393-400.
144. Sheppard, K. A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., and Collins, T. (1998). Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273, 29291-29294.
145. Shipley, J. M., and Waxman, D. J. (2006). Aryl hydrocarbon receptorindependent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 213, 87-97.
146. Smith, K. J., Murray, I. A., Tanos, R., Tellew, J., Boitano, A. E., Bisson, W. H., Kolluri, S. K., Cooke, M. P., and Perdew, G. H. (2011). Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. J. Pharmacol. Exp. Ther. 338, 318-327.
147. Soshilov, A., and Denison, M. S. (2008). Role of the Per/Arnt/Sim domains in ligand-dependent transformation of the aryl hydrocarbon receptor. J. Biol. Chem. 283, 32995-32305.
148. Stevens, E. A., Mezrich, J. D., and Bradfield, C. A. (2009). The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 127, 299-311.
149. Swanson, H. I., Chan, W. K., and Bradfield, C. A. (1995). DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. Biol. Chem. 270, 26292-26302.
150. Swedenborg, E., and Pongratz, I. (2010). AhR and ARNT modulate ER signaling. Toxicology 268, 132-138.
151. Sweeney, M. H., and Mocarelli, P. (2000). Human health effects after exposure to 2,3,7,8-TCDD. Food Addit. Contam. 17, 303-316.
152. Tian, Y. (2009). Ah receptor and NF-kB interplay on the stage of the epigenome. Biochem. Pharmacol. 77, 670-680.
153. Tijet, N., Boutros, P. C., Moffat, I. D., Okey, A. B., Tuomisto, J., and Pohjanvirta, R. (2005). Aryl hydrocarbon receptor regulates distinct dioxindependent and dioxin-independent gene batteries. Mol. Pharmacol. 69, 140-153.
154. Tompkins, L. M., Li, H., Li, L., Lynch, C., Xie, Y., Nakanishi, T., Ross, D. D., and Wang, H. (2010). A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells. Biochem. Pharmacol. 80, 1754-1761.
155. Uemura, H., Arisawa, K., Hiyoshi, M., Kitayama, A., Takami, H., Sawachika, F., Dakeshita, S., Nii, K., Satoh, H., Sumiyoshi, Y., et al. (2009). Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ. Health Perspect. 117, 568-573.
156. Viluksela, M., Unkila, M., Pohjanvirta, R., Tuomisto, J. T., Stahl, B. U., Rozman, K. K., and Tuomisto, J. (1999). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains. Arch. Toxicol. 73, 323-336.
157. Vogel, C. F., Sciullo, E., Li, W., Wong, P., Lazennec, G., and Matsumura, F. (2007). RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol. Endocrinol. 21, 2941-2955.
158. Wang, F., Samudio, I., and Safe, S. (2001). Transcriptional activation of cathepsin D gene expression by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Cell. Endocrinol. 172, 91-103.
159. Watabe, Y., Nazuka, N., Tezuka, M., and Shimba, S. (2010). Aryl hydrocarbon receptor functions as a potent coactivator of E2F1-dependent transcription activity. Biol. Pharm. Bull. 33, 389-397.
160. Wei, Y. D., Bergander, L., Rannug, U., and Rannug, A. (2000). Regulation of CYP1A1 transcription via the metabolism of the tryptophan-derived 6-formylindolo[3,2-b]carbazole. Arch. Biochem. Biophys. 383, 99-107.
161. Whelan, F., Hao, N., Furness, S. G. B., Whitelaw, M. L., and Chapman-Smith, A. (2010). Amino acid substitutions in the aryl hydrocarbon receptor (AhR) ligand binding domain reveal YH439 as an atypical AhR activator. Mol. Pharmacol. 77, 1037-1046.
162. White, S. S., and Birnbaum, L. S. (2009). An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 27, 197-211.
163. Whitlock, J. P., Jr. (1999). Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39, 103-125.
164. Widerak, M., Ghoneim, C., Dumontier, M. F., Quesne, M., Corvol, M. T., and Savouret, J. F. (2006). The aryl hydrocarbon receptor activates the retinoic acid receptor alpha through SMRT antagonism. Biochimie 88, 387-397.
165. Wincent, E., Amini, N., Luecke, S., Glatt, H., Bergman, J., Crescenzi, C., Rannug, A., and Rannug, U. (2009). The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans. J. Biol. Chem. 284, 2690-2696.
166. Yao, E. F., and Denison, M. S. (1992). DNA sequence determinants for binding of transformed Ah receptor to a dioxin responsive element. Biochemistry 31, 5060-5067.
167. Zhang, S., Rowlands, C., and Safe, S. (2008). Ligand-dependent interactions of the Ah receptor with coactivators in a mammalian two-hybrid assay. Toxicol. Appl. Pharmacol. 227, 196-206.
168. Zhao, B., Degroot, D., Hayashi, A., He, G., and Denison, M. S. (2010). CH223191 is a ligand-selective antagonist of the Ah (dioxin) receptor. Toxicol. Sci. 117, 393-403.